BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Open Monoclonal Technology Inc.

Headquarters: Palo Alto, CA, United States of America
Website: N/A
Year Founded: 2007
Status: Acquired

BioCentury | Sep 1, 2017
Finance

Armo's China network

Why Armo brought Chinese investors on board for its $67M series C-1 round
BioCentury | Sep 1, 2017
Financial News

Armo raises $67M series C-1 round

BioCentury | Aug 29, 2017
Financial News

Armo raises $67M series C-1 round

BioCentury | Jul 25, 2016
Company News

Open Monoclonal Technology, WuXi PharmaTech deal

BioCentury | Feb 15, 2016
Finance

Combo collector

Why investors bought into Armo's immunotherapy combo strategy
BioCentury | Nov 16, 2015
Company News

Open Monoclonal Technology, Armo BioSciences deal

BioCentury | Oct 26, 2015
Company News

Open Monoclonal Technology, Five Prime deal

BioCentury | Jul 13, 2015
Company News

Open Monoclonal Technology, Amgen deal

BioCentury | Mar 30, 2015
Company News

Open Monoclonal Technology, Celgene deal

Items per page:
1 - 10 of 27